Asuragen Signs Exclusive Agreement for CML In Vitro Diagnostic

Diagnostic development company Asuragen Inc said that it has signed an exclusive agreement with Life Technologies Corp to develop and distribute worldwide an in-vitro diagnostic test for chronic myeloid leukemia (CML) patients.
TradingMarkets